Genedrive (GDR)

Sector:

Health Care

Index:

FTSE AIM All-Share

 0.78p
   
  • Change Today:
      0.000p
  • 52 Week High: 2.93p
  • 52 Week Low: 0.74p
  • Currency: UK Pounds
  • Shares Issued: 624.90m
  • Volume: 974,560
  • Market Cap: £4.84m
  • RiskGrade: 747

Latest ShareCast News

Genedrive flags doubling of full-year income

By Josh White

Date: Monday 11 Aug 2025

(Sharecast News) - Genedrive said in an update on Monday that its full-year income for the 12 months ended June doubled to around £1m, from £0.5m a year earlier, driven by stronger second-half sales.

Genedrive secures CE certification for CYP2C19 ID Kit

By Josh White

Date: Friday 30 May 2025

(Sharecast News) - Genedrive announced on Friday that it has secured CE certification for its CYP2C19 ID Kit under the European In Vitro Diagnostic Regulation (IVDR), allowing the pharmacogenetic test to be marketed and used across the EU and in certain non-European countries that recognise CE-IVD marking.

Genedrive upbeat on publication of clinical performance data

By Josh White

Date: Friday 27 Dec 2024

(Sharecast News) - Point-of-care pharmacogenetic testing specialist Genedrive announced on Friday that clinical performance data for its Genedrive CYP2C19-ID Kit had been published in the Journal of Molecular Biology.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genedrive Market Data

Currency UK Pounds
Share Price 0.78p
Change Today 0.000p
% Change 0.00 %
52 Week High 2.93p
52 Week Low 0.74p
Volume 974,560
Shares Issued 624.90m
Market Cap £4.84m
RiskGrade 747

Genedrive Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
18.70% above the market average18.70% above the market average18.70% above the market average18.70% above the market average18.70% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Price Trend
96.28% below the market average96.28% below the market average96.28% below the market average96.28% below the market average96.28% below the market average
88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average
Income Not Available
Growth
67.04% above the market average67.04% above the market average67.04% above the market average67.04% above the market average67.04% above the market average
88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average

Genedrive Dividends

No dividends found

Trades for 28-Aug-2025

Time Volume / Share Price
15:22 18,767 @ 0.79p
12:57 675,058 @ 0.77p
11:29 24,717 @ 0.79p
11:16 100,000 @ 0.77p
11:10 30,018 @ 0.79p

Genedrive Key Personnel

CFO Russell Shaw
CEO Gino Miele

Top of Page